ORASURE TECHNOLOGIES, INC Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (4 lists). Names and jurisdictions are as filed.
- 2026-03-09: Subsidiary DNA Genotek Inc.; Jurisdiction Canada.
- 2026-03-09: Subsidiary Sherlock Biosciences, Inc; Jurisdiction Delaware.
- 2026-03-09: Subsidiary Sense Biodetection Limited; Jurisdiction England and Wales.
- 2026-03-09: Subsidiary BioMedomics, Inc.; Jurisdiction Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-09 | DNA Genotek Inc. | Canada |
| 2026-03-09 | Sherlock Biosciences, Inc | Delaware |
| 2026-03-09 | Sense Biodetection Limited | England and Wales |
| 2026-03-09 | BioMedomics, Inc. | Delaware |
| 2025-03-07 | DNA Genotek Inc. | Canada |
| 2025-03-07 | Sherlock Biosciences, Inc | Delaware |
| 2025-03-07 | Sherlock Securities Corporation | Massachusetts |
| 2025-03-07 | 221B Foundation | Delaware |
| 2025-03-07 | Sense Biodetection Limited | England and Wales |
| 2025-03-07 | Sense Biodetection Inc | Delaware |
| 2014-03-14 | DNA Genotek Inc. | Canada |
| 2013-03-13 | DNA Genotek Inc. | Canada |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |